Evidence map›Paper›PMID 23110824›Full record

ReviewEpilepsy & behavior : E&B2013

Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Adam L Hartman, Carl E Stafstrom

Abstract readReview
In one paragraph

Review in Epilepsy & behavior : E&B, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. d-Leucine: Evaluation in an epilepsy model.Epilepsy & behavior : E&B · 2018
    Article
  5. Bioenergetic Mechanisms of Seizure Control.Frontiers in cellular neuroscience · 2018
    Review
  6. Article
  7. Potent anti-seizure effects of D-leucine.Neurobiology of disease · 2015
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Adam L HartmanDepartment of Neurology, Johns Hopkins Medicine, Baltimore, MD, USA. Ahartma2@jhmi.edu
Carl E Stafstrom
Johns Hopkins Medicine · USUniversity of Wisconsin–Madison · US

Funding

Mitochodrial Dynamics in Metabolism-based Therapies for EpilepsyK08NS070931 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HARTMAN, ADAM L · 2011 to 2015
$932k
NINDS NIH HHS K08 NS070931NINDS NIH HHS K08NS070931
6 · The paper itself

Abstract

The continued occurrence of refractory seizures in at least one-third of children and adults with epilepsy, despite the availability of almost 15 conventional and novel anticonvulsant drugs, speaks to a dire need to develop novel therapeutic approaches. Cellular metabolism, the critical pathway by which cells access and utilize energy, is essential for normal neuronal function. Furthermore, mounting evidence suggests direct links between energy metabolism and cellular excitability. The high-fat, low-carbohydrate ketogenic diet has been used as a treatment for drug-refractory epilepsy for almost a century. Yet, the multitude of alternative therapies to target aspects of cellular metabolism and hyperexcitability is almost untapped. Approaches discussed in this review offer a wide diversity of therapeutic targets that might be exploited by investigators in the search for safer and more effective epilepsy treatments.

Indexed as

Diet, KetogenicAnimalsAnticonvulsantsCaloric RestrictionHumansKetone BodiesSeizuresSirolimusTOR Serine-Threonine KinasesTreatment OutcomeAnticonvulsantsKetone BodiesSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID23110824
PMCPMC3562425
OpenAlexW2028736848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.